.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Cardiovascular Clinical Consult

EP 1: REDUCE-IT Trial Data Updates: Key Takeaways

September 11th 2020

A discussion on recent data updates from the REDUCE-IT trial, and their practical implications for physicians managing cardiovascular risk.

EP 2: The Potential CV Impact of Triglyceride Level Reduction

September 11th 2020

An expert physician discusses the role of agents that reduce triglyceride levels and the potential on cardiovascular risk.

EP 3: CV Risk Stratification Decision Factors

August 14th 2020

A discussion on which factors to consider when assessing the need for management/reduction of cardiovascular risk.

EP 4: CV Health: Risk Prevention, Challenges, Education

August 14th 2020

A key opinion leader discusses effective risk prevention measures and challenges to reducing adverse events. He also considers effective educational resources for self-care.

EP 5: New Approaches in Targeting Triglycerides for the Reduction of Cardiovascular Risks

August 11th 2020

This article reviews the evolving therapeutic landscape for lowering LDL-C and cardiovascular risk, with an emphasis on the role of omega-3 fatty acids.